Filter
1725
Filtered Results: 1725
Text search:
National
Medicines
Regulatory
Authority
Featured
Recommendations
164
New Publications
481
Language
Document type
No document type
829
Studies & Reports
325
Guidelines
290
Manuals
119
Strategic & Response Plan
101
Fact sheets
25
Situation Updates
15
Training Material
12
Resource Platforms
4
Brochures
3
Infographics
1
Online Courses
1
Countries / Regions
Kenya
64
Global
63
India
59
Ethiopia
49
Uganda
37
Nigeria
35
South Africa
35
Liberia
34
Western and Central Europe
33
Tanzania
29
Ghana
28
Zambia
28
Sierra Leone
26
Ukraine
24
Nepal
23
Africa
23
Latin America and the Carribbean
22
South–East Asia Region
21
Bangladesh
21
Rwanda
20
Malawi
18
Eastern Europe
17
Myanmar / Burma
15
Syria
13
West and Central Africa
13
Namibia
13
Lesotho
12
Zimbabwe
12
Philippines
12
East and Southern Africa
11
Guinea
9
Eswatini/ Swaziland
9
Asia
8
Middle East and North Africa
8
Cambodia
7
Botswana
7
Congo, Democratic Republic of
6
Indonesia
6
Mozambique
5
USA
5
Eastern Europe and Central Asia
5
Sudan
5
Pakistan
5
Senegal
4
Jordan
4
Western Pacific Region
4
Moldova
4
Georgia
4
Somalia
4
Tajikistan
3
Thailand
3
Benin
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Afghanistan
3
Haiti
3
Germany
3
North America
3
Iran
2
Peru
2
Turkmenistan
2
Bosnia and Herzegovina
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Russia
2
South Sudan
2
Ecuador
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Australia
1
Kazakhstan
1
Chile
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Belarus
1
Bolivia
1
Brazil
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
648
Clinical Guidelines
145
Public Health
120
Women & Child Health
67
Key Resources
67
Pharmacy & Technologies
50
Capacity Building
10
Toolboxes
AMR
146
COVID-19
121
Pharmacy
120
HIV
119
TB
103
Mental Health
70
Rapid Response
63
Planetary Health
61
Caregiver
55
Global Health Education
37
Ebola & Marburg
36
NTDs
31
NCDs
29
Conflict
28
Disability
20
Specific Hazards
19
Refugee
16
Natural Hazards
15
Health Financing Toolbox
9
Zika
9
Polio
8
Cholera
4
Malaria
3
Social Ethics
2
This guideline aims to improve the quality of donations and the management thereof and serve as the basis for policies of the State and other organizations in the giving and receiving of donations of medicines, medical devices and IVDs.
Over the last three or four decades, there has been an enorm...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic...
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl...
